NDC 0008-0100 – Besponsa
Inotuzumab Ozogamicin .25 mg/mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC0008-0100
Product details
- Brand name
- Besponsa
- Generic name
- Inotuzumab ozogamicin
- Labeler
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761040
- Marketed since
- August 18, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- CD22-directed Immunoconjugate
Active ingredients
- Inotuzumab Ozogamicin .25 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0008-0100-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0008-0100-01) / 4 mL in 1 VIAL, SINGLE-DOSE | Aug 18, 2017 |